MedTrace Logo

Evaluation of Partial and Total Femoral Replacement

NCT03045536 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-04-25

No results posted yet for this study

Summary

Several surgical options for the reconstruction of massive bone defects have been described and include biologic methods with autografts and allografts, and the use of tumor endoprostheses (total femoral replacement, TFR). Several types of modular TFR are available, but nevertheless unpredictable outcomes and high complication rates have been described from most authors. The aim of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients with and without malignant disease.

Conditions

  • Survival, Prostheses

Interventions

DEVICE

MML (Fa. ESKA/Orthodynamics)

Classification of complications according to MSTS

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • norbert harrasser · Klinikum rechts der Isar

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-03-01
Completion
2019-04-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03045536 on ClinicalTrials.gov